Mirum Pharmaceuticals预计2027年第一季度公布Volixibat治疗PBC的Vantage二期B阶段研究顶线数据

美股速递
May 04

Mirum Pharmaceuticals宣布,针对原发性胆汁性胆管炎(PBC)的Volixibat药物Vantage二期B阶段临床研究,预计将于2027年第一季度获得顶线数据结果。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10